Status:
ACTIVE_NOT_RECRUITING
High Resolution Micro OCT Imaging
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cystic Fibrosis
COPD
Eligibility:
All Genders
14+ years
Brief Summary
The purpose of this study is to learn about using the imaging to make images of the lungs and nose with the long-term goal of the research leading to potential treatments and new therapies for patient...
Detailed Description
Lung Disease is the predominate cause of morbidity and mortality in patients with cystic fibrosis (CF). A better understanding of the primary pathogenesis of CF is essential in order to reveal the fea...
Eligibility Criteria
Inclusion
- THE INCLUSION CRITERIA:
- Patients diagnosed with CF or healthy normal controls with no respiratory disease
- Patients must be over the age of 14
- Patient must be able to give informed consent
- THE EXCLUSION CRITERIA:
- Patients with recent respiratory infection requiring antibiotics or corticosteroids in the last 4 weeks (excluding routine perioperative antibiotics)
- Patients with major sinus surgery that will alter the nasal anatomy and preclude imaging of the nares
- Any condition that in the opinion of the investigator will alter the safety of pilot testing in the operating room
- Female subjects who are pregnant
Exclusion
Key Trial Info
Start Date :
April 15 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03256773
Start Date
April 15 2016
End Date
December 31 2026
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233